Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock - $0.01 Par Value
-
Shares outstanding
-
46,382,189
-
Number of holders
-
254
-
Total 13F shares, excl. options
-
42,331,138
-
Shares change
-
-995,716
-
Total reported value, excl. options
-
$843,184,184
-
Value change
-
-$19,844,468
-
Put/Call ratio
-
1150%
-
Number of buys
-
97
-
Number of sells
-
-114
-
Price
-
$19.92
Significant Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) as of Q2 2024
294 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value as of Q2 2024.
AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) has 254 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42,331,138 shares
of 46,382,189 outstanding shares and own 91% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7,011,219 shares), VANGUARD GROUP INC (5,270,136 shares), RGM Capital, LLC (3,171,455 shares), DIMENSIONAL FUND ADVISORS LP (2,577,635 shares), T. Rowe Price Investment Management, Inc. (2,217,793 shares), WESTWOOD HOLDINGS GROUP INC (2,084,117 shares), STATE STREET CORP (1,824,335 shares), BROWN ADVISORY INC (1,670,783 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1,419,995 shares), and Paradice Investment Management LLC (1,344,949 shares).
This table shows the top 254 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.